A detailed history of Callan Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Callan Capital, LLC holds 6,388 shares of JNJ stock, worth $1.06 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,388
Previous 5,648 13.1%
Holding current value
$1.06 Million
Previous $893,000 4.48%
% of portfolio
0.08%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $106,841 - $116,757
740 Added 13.1%
6,388 $933,000
Q1 2024

May 03, 2024

BUY
$155.22 - $162.74 $200,233 - $209,934
1,290 Added 29.6%
5,648 $893,000
Q4 2023

Feb 02, 2024

BUY
$145.6 - $158.88 $58,822 - $64,187
404 Added 10.22%
4,358 $683,000
Q3 2023

Nov 06, 2023

BUY
$155.75 - $174.48 $47,503 - $53,216
305 Added 8.36%
3,954 $615,000
Q2 2023

Aug 04, 2023

SELL
$154.35 - $166.11 $83,194 - $89,533
-539 Reduced 12.87%
3,649 $603,000
Q1 2023

Jun 13, 2023

SELL
$151.05 - $180.26 $236,091 - $281,746
-1,563 Reduced 27.18%
4,188 $649,000
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $236,091 - $281,746
-1,563 Reduced 27.18%
4,188 $649,000
Q4 2022

Jun 13, 2023

BUY
$160.2 - $179.79 $250,392 - $281,011
1,563 Added 37.32%
5,751 $1.02 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $274,102 - $307,620
1,711 Added 42.35%
5,751 $1.02 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $447,529 - $497,988
2,774 Added 219.12%
4,040 $660,000
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $7,400 - $8,184
-44 Reduced 3.36%
1,266 $225,000
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $68,316 - $77,582
-432 Reduced 24.8%
1,310 $232,000
Q4 2021

Jan 21, 2022

BUY
$155.93 - $173.01 $271,630 - $301,383
1,742 New
1,742 $298,000
Q3 2021

Oct 15, 2021

SELL
$161.5 - $179.47 $245,641 - $272,973
-1,521 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $242,569 - $260,197
1,521 New
1,521 $251,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.